ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION

ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION

Objective: to assess whether adalimumab (AD) can be gradually discontinued during continuous methotrexate (MTX) use in patients with early rheumatoid arthritis (ERA).Subjects and methods. Within the REMARCA (the Russian study of methotrexate and biological agents in early active arthritis) study, th...

Full description

Bibliographic Details
Main Authors: N. V. Demidova, E. A. Galushko, S. I. Glukhova, N. M. Savushkina, A. M. Satybaldyev, M. V. Cherkasova, N. V. Khoroshko, S. V. Maglevanyi, A. V. Gordeev
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2018-07-01
Series:Научно-практическая ревматология
Subjects:
early rheumatoid arthritis
adalimumab
remission
Online Access:https://rsp.mediar-press.net/rsp/article/view/2565

Internet

https://rsp.mediar-press.net/rsp/article/view/2565

Similar Items